SERAM 2026: Where Europe’s Lung Cancer Screening Moves from Pilot to Infrastructure
SERAM 2026, one of Europe’s leading radiology congresses, will bring together clinical experts, researchers, and industry leaders to discuss the evolving role of imaging and AI in modern healthcare.
Organized by the Spanish Society of Medical Radiology (SERAM), the conference serves as a key platform for exploring how radiology is transitioning from diagnostic imaging toward data-driven, system-level healthcare delivery.
Coreline Soft will participate in SERAM 2026 to present its AI-powered solutions designed for lung cancer screening (LCS) and multi-disease analysis in real-world clinical environments.
Event Details
• Event: SERAM 2026 (Sociedad Española de Radiología Médica)
• Location: Palacio de Congresos in Valencia, Spain
• Dates: May 20–23, 2026
• Coreline Soft Booth: #41 (with Lunit)
From Pilot Programs to Scalable National Screening
Across Europe, lung cancer screening is entering a new phase.
What began as pilot initiatives is now expanding into multi-site, population-based national programs.
As this transition unfolds, the focus is shifting:
• From algorithm performance → to real-world clinical deployment
• From single-site validation → to multi-center collaboration
• From detection accuracy → to operational stability and quality management
SERAM 2026 is expected to highlight these shifts, with increasing attention on how screening programs are designed, implemented, and sustained at scale.
Why Infrastructure Now Matters
National lung cancer screening programs require more than imaging capabilities.
They demand a structured operational framework, including:
• Double reading workflows
• Structured reporting systems
• Longitudinal follow-up and patient tracking
• Multi-site data standardization and quality assurance
In this context, AI is no longer positioned as a standalone diagnostic tool.
It is becoming a core infrastructure component that enables consistent and scalable screening operations.
Coreline Soft’s Approach at SERAM 2026
At SERAM 2026, Coreline Soft will showcase its integrated AI solutions designed to support the operational demands of lung cancer screening programs.
Key Solutions
• AVIEW LCS / AVIEW LCS Plus : AI-based detection and quantitative analysis of pulmonary nodules
• One-CT Multi-Disease Analysis : Simultaneous assessment of lung cancer, COPD, and cardiovascular risk from a single CT scan
These solutions are designed to address critical challenges in real-world screening environments, including reading consistency, data integration, and quality assurance.
Built on Proven European Experience
Coreline Soft’s presence at SERAM 2026 builds on its experience across major European lung cancer screening initiatives, including:
• HANSE (Germany)
• RISP national screening project (Italy)
• 4-IN THE LUNG RUN (EU multi-country trial)
These projects have provided practical insights into how AI can be deployed within multi-site screening networks, beyond controlled pilot environments.
Meet Us at SERAM 2026
At SERAM 2026, visitors will have the opportunity to explore
• How AI supports multi-center screening operations
• Real-world workflows for longitudinal lung nodule tracking
• Infrastructure approaches to quality assurance and compliance
Coreline Soft will demonstrate how its solutions translate clinical requirements into scalable, operational systems.
Lung cancer screening in Europe is no longer defined by technology alone. It is increasingly shaped by how effectively programs can be designed, standardized, and operated at scale.
SERAM 2026 represents a key moment in this transition.
Coreline Soft will be there to demonstrate how AI can move beyond detection — and become part of the infrastructure that enables sustainable screening systems.
Visit us at SERAM 2026 (Booth #15) to explore AI-powered lung screening infrastructure in action.
